Key Takeaways
- • Marathon Petroleum (MPC) reported Q2 2026 earnings of $17.73 per diluted share, significantly surpassing analyst consensus estimate of $14.52 per share and demonstrating sustained operational outperformance.
- • Net income for Q2 2026 reached $5.1 billion, representing a 323% increase year-over-year from Q2 2025, driven by strong refining margins and operational execution.
- • Revenue in Q2 2026 totaled $52.3 billion, up 55% from the prior-year quarter, with profit margin expanding to 9.8% from 3.6% in Q2 2025—a 270 basis point improvement.
- • Full-year 2025 results demonstrated robust performance with $13.22 per diluted share and 105% margin capture, complemented by $8.3 billion in operating cash flow and $4.5 billion in capital returns to shareholders.
- • Q1 2026 earnings per share of $1.65 exceeded consensus by 118.6%, indicating consistent beat-rate momentum through the first half of 2026.
Summary
Marathon Petroleum Corporation has delivered exceptional financial performance in 2026, with Q2 results substantially exceeding market expectations across all key metrics. The company reported diluted earnings per share of $17.73 against a consensus estimate of $14.52, representing a 22% outperformance. This marks the second consecutive quarter of significant earnings beats, following Q1 2026's 118.6% EPS surprise, where the company reported $1.65 per share versus a $0.7548 consensus estimate.
Net income attributable to MPC reached $5.1 billion in Q2 2026, reflecting dramatic year-over-year growth of 323% compared to Q2 2025. The substantial increase underscores improving operational leverage and margin capture in Marathon's refining and midstream operations. Revenue expanded to $52.3 billion in the second quarter, up 55% year-over-year, while the company's profit margin improved notably to 9.8% from 3.6% in the prior-year period—representing a 270 basis point expansion that signals enhanced pricing power and operational efficiency.
Prior-year 2025 results provided strong foundation for this performance trajectory. Full-year 2025 net income totaled $4.0 billion, or $13.22 per diluted share, compared with $3.4 billion, or $10.08 per share in 2024. The company achieved 105% margin capture and 94% refining utilization during 2025, demonstrating disciplined operational and commercial execution. Operating cash generation of $8.3 billion enabled peer-leading capital returns of $4.5 billion to shareholders in 2025, with MPLX's growing distribution positioned to fund MPC's 2026 dividend and standalone capital allocation.
The sustained earnings outperformance has generated positive momentum in equity research coverage, with seven earnings estimates moving higher for the full year 2026 and no downward revisions. Analyst consensus reflects a "Buy" rating with 21% of 14 analysts recommending a Strong Buy and 50% recommending Buy, underscoring confidence in Marathon's operational execution and capital allocation strategy.
Net income attributable to MPC reached $5.1 billion in Q2 2026, reflecting dramatic year-over-year growth of 323% compared to Q2 2025. The substantial increase underscores improving operational leverage and margin capture in Marathon's refining and midstream operations. Revenue expanded to $52.3 billion in the second quarter, up 55% year-over-year, while the company's profit margin improved notably to 9.8% from 3.6% in the prior-year period—representing a 270 basis point expansion that signals enhanced pricing power and operational efficiency.
Prior-year 2025 results provided strong foundation for this performance trajectory. Full-year 2025 net income totaled $4.0 billion, or $13.22 per diluted share, compared with $3.4 billion, or $10.08 per share in 2024. The company achieved 105% margin capture and 94% refining utilization during 2025, demonstrating disciplined operational and commercial execution. Operating cash generation of $8.3 billion enabled peer-leading capital returns of $4.5 billion to shareholders in 2025, with MPLX's growing distribution positioned to fund MPC's 2026 dividend and standalone capital allocation.
The sustained earnings outperformance has generated positive momentum in equity research coverage, with seven earnings estimates moving higher for the full year 2026 and no downward revisions. Analyst consensus reflects a "Buy" rating with 21% of 14 analysts recommending a Strong Buy and 50% recommending Buy, underscoring confidence in Marathon's operational execution and capital allocation strategy.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.